Results 141 to 150 of about 51,976 (269)

Recurrent Pneumothorax With Bronchopleural Fistula in Primary Multidrug‐Resistant Pulmonary Tuberculosis: A Challenging Case

Respirology Case Reports, Volume 14, Issue 5, May 2026.
A 41‐year‐old man with primary multidrug‐resistant pulmonary tuberculosis (MDR‐TB) developed recurrent pneumothorax and a bronchopleural fistula (BPF). Despite persistent air leak (PAL) after initial video‐assisted thoracoscopic surgery (VATS), definitive open thoracotomy with decortication and fistula repair led to sustained lung re‐expansion.
Primawati, Winariani Koesoemoprodjo, Mohamad Rizki   +2 more
wiley   +1 more source

Risk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US

The Journal of Dermatology, Volume 53, Issue 5, Page 758-773, May 2026.
ABSTRACT Vitiligo is a chronic autoimmune depigmenting disease characterized by loss of pigment in the skin, hair, or both. As treatment options evolve, particularly with the emergence of oral Janus kinase inhibitors and dual Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor, it is essential to assess ...
Kennedy Cook, Nada M. Elbuluk, Roni Adiri, Alexandre Lejeune, Thomas Edwards, Milena A. Gianfrancesco, Scott P. Kelly, Tatjana Lukic, Edward Nagy, Samantha K. Kurosky, Lynne Napatalung, Iltefat Hamzavi   +11 more
wiley   +1 more source

Exploring the histopathological signature of repeat‐mediated Fuchs endothelial corneal dystrophy

Acta Ophthalmologica, Volume 104, Issue 3, Page 333-341, May 2026.
Abstract Purpose To determine the histological differences between Fuchs endothelial corneal dystrophy (FECD) cases with and without the most common genetic risk factor, expansion of a CTG repeat (CTG18.1) within the TCF4 gene. Methods Formalin‐fixed paraffin‐embedded corneal tissues were compared retrospectively, and CTG18.1 status was determined from
Anne‐Marie S. Kladny, Nihar Bhattacharyya, Marcos Abreu Costa, Stephen J. Tuft, Caroline Thaung, Alice E. Davidson   +5 more
wiley   +1 more source

Köbner Phenomenon in a Rituximab-Treated Pemphigus Patient: Beware Disease Activity

Dermatology Practical & Conceptual, 2019
Soheil Tavakolpour, Hamidreza Mahmoudi, Nika Kianfar, Shayan Dasdar, Maryam Daneshpazhooh   +4 more
doaj   +1 more source

Bruton tyrosine kinase (Btk) in neutrophils is indispensable for initiating and maintaining skin inflammation in a model of pemphigoid diseases

British Journal of Pharmacology, Volume 183, Issue 10, Page 2446-2463, May 2026.
Background and Purpose Bruton tyrosine kinase (Btk) is essential for B cell function. Its role in myeloid cells is less understood. Greater insights into Btk significance in myeloid cells are needed to evaluate its potential as a therapeutic target during the effector phase of antibody‐induced autoimmune diseases, where inhibiting autoantibody ...
Henning Olbrich, Paul Schilf, Sripriya Murthy, Sina Gonther, Mareike Neumann, Christoph M. Hammers, Jasper N. Pruessmann, Christian D. Sadik   +7 more
wiley   +1 more source

Nonbullous erythrodermic pemphigoid with florid lymphadenopathy, response to dupilumab

JAAD Case Reports, 2021
Arjun Bal, BS, MA, Adam Sorensen, DO, Sharon M. Ondreyco, MD   +2 more
doaj   +1 more source

Bispecific Dual‐Immune Checkpoint Inhibitor Associated Cutaneous Toxicity: A Report of Lorigerlimab Adverse Skin Reaction in Two Cancer Patients

Journal of Cutaneous Pathology, Volume 53, Issue 5, Page 422-426, May 2026.
ABSTRACT Lorigerlimab is a dual bispecific antibody (BsAb) targeting cytotoxic T‐lymphocyte‐associated protein 4 and programmed cell death protein 1 that is used for treatment of advanced solid cancers such as metastatic castration‐resistant prostate carcinoma.
Niloofar Sina, Fiorinda Muhaj, Volha Lenskaya, Doina Ivan, Victor G. Prieto, Jonathan L. Curry   +5 more
wiley   +1 more source

Wells syndrome: clinical findings and treatment management in a large cohort of 48 patients

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 5, Page 644-656, May 2026.
Summary Background and Objectives: Wells syndrome (WS) is a rare inflammatory skin disorder typically characterized by erythematous, edematous, and pruritic plaques. Despite its distinct histopathological features, WS remains an underdiagnosed disease due to its variable clinical presentations and overlap with other dermatological conditions.
Marco Adriano Chessa, Silvia Robuffo, Tullio Brunetti, Luca Rapparini, Bianca Maria Piraccini, Cosimo Misciali, Beatrice Raone, Iria Neri, Federica Filippi   +8 more
wiley   +1 more source

Prevalence and Severity of Sleep Disorders in Patients With Mycosis Fungoides: A Case-Control Study

Journal of Skin Cancer
Ahmad Vafaeian, Aidin Shahilooy, Maryam Daneshpazhooh, Robabeh Abedini, Farid Mohamadi, Ala Ehsani, Hamidreza Mahmoudi   +6 more
doaj   +1 more source

Bullous Pilomatricoma of the Neck With Lymphatic Involvement: A Case Report. [PDF]

Cureus
Roa Álvarez G, Shuchleib Cukiert M, Hernández Altamirano FR, Vega Memije ME.   +3 more
europepmc   +1 more source